Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 191

1.

Know your history.

Klok FA.

Thromb Res. 2019 Jul 24. pii: S0049-3848(19)30311-1. doi: 10.1016/j.thromres.2019.07.018. [Epub ahead of print] No abstract available.

PMID:
31358303
2.

Quality of life and functional limitations after pulmonary embolism and its prognostic relevance.

Keller K, Tesche C, Gerhold-Ay A, Nickels S, Klok FA, Rappold L, Hasenfuß G, Dellas C, Konstantinides SV, Lankeit M.

J Thromb Haemost. 2019 Jul 25. doi: 10.1111/jth.14589. [Epub ahead of print]

PMID:
31344319
3.

Evaluation of the predictive value of the bleeding prediction score VTE-BLEED for recurrent venous thromboembolism.

Klok FA, Presles E, Tromeur C, Barco S, Konstantinides SV, Sanchez O, Pernod G, Raj L, Robin P, Le Roux PY, Hoffman C, Mélac S, Bertoletti L, Girard P, Laporte S, Mismetti P, Meyer G, Leroyer C, Couturaud F; PADIS‐PE Investigators.

Res Pract Thromb Haemost. 2019 May 25;3(3):364-371. doi: 10.1002/rth2.12214. eCollection 2019 Jul.

4.

[Andexanet alfa: the best antidote for factor Xa inhibitors?]

Klok FA, Huisman MV.

Ned Tijdschr Geneeskd. 2019 Jun 27;163. pii: D3894. Dutch.

PMID:
31283119
5.

Duration of anticoagulant treatment for unprovoked deep-vein thrombosis - is prolonged long enough?

Huisman MV, Klok FA.

Haematologica. 2019 Jul;104(7):1300-1301. doi: 10.3324/haematol.2019.218909. No abstract available.

6.

Diagnosing Recurrent DVT of the Leg by Two Different Non-Contrast-Enhanced Magnetic Resonance Direct Thrombus Imaging Techniques: A Pilot Study.

Dronkers CEA, Klok FA, van Langevelde K, Šrámek A, van Haren GR, Huisman MV, de Roos A, Kroft LJM.

TH Open. 2019 Feb 6;3(1):e37-e44. doi: 10.1055/s-0039-1678683. eCollection 2019 Jan.

7.

Chest X-Ray Not Routinely Indicated Prior to the YEARS Algorithm in the Diagnostic Management of Suspected Pulmonary Embolism.

van der Pol LM, Tromeur C, Faber LM, van der Hulle T, Kroft LJM, Mairuhu ATA, de Roos A, Huisman MV, Klok FA.

TH Open. 2019 Jan 8;3(1):e22-e27. doi: 10.1055/s-0038-1676812. eCollection 2019 Jan.

8.

Diagnosis of Suspected Pulmonary Embolism in Pregnancy. Reply.

van der Pol LM, Klok FA, Huisman MV; Artemis Study Investigators.

N Engl J Med. 2019 Jun 20;380(25):e49. doi: 10.1056/NEJMc1905283. No abstract available.

PMID:
31216413
9.

Ruling out pulmonary embolism across different subgroups of patients and healthcare settings: protocol for a systematic review and individual patient data meta-analysis (IPDMA).

Geersing GJ, Kraaijpoel N, Büller HR, van Doorn S, van Es N, Le Gal G, Huisman MV, Kearon C, Kline JA, Moons KGM, Miniati M, Righini M, Roy PM, van der Wall SJ, Wells PS, Klok FA.

Diagn Progn Res. 2018 Jul 2;2:10. doi: 10.1186/s41512-018-0032-7. eCollection 2018.

10.

Measuring functional limitations after venous thromboembolism: A call to action.

Klok FA, Barco S, Siegerink B.

Thromb Res. 2019 Jun;178:59-62. doi: 10.1016/j.thromres.2019.04.003. Epub 2019 Apr 7. Review.

PMID:
30980999
11.

Usefulness of standard computed tomography pulmonary angiography performed for acute pulmonary embolism for identification of chronic thromboembolic pulmonary hypertension: results of the InShape III study.

Ende-Verhaar YM, Meijboom LJ, Kroft LJM, Beenen LFM, Boon GJAM, Middeldorp S, Nossent EJ, Symersky P, Huisman MV, Bogaard HJ, Noordegraaf AV, Klok FA.

J Heart Lung Transplant. 2019 Jul;38(7):731-738. doi: 10.1016/j.healun.2019.03.003. Epub 2019 Mar 15.

PMID:
30962147
12.

Atrial fibrillation and cancer - An unexplored field in cardiovascular oncology.

Chu G, Versteeg HH, Verschoor AJ, Trines SA, Hemels MEW, Ay C, Huisman MV, Klok FA.

Blood Rev. 2019 May;35:59-67. doi: 10.1016/j.blre.2019.03.005. Epub 2019 Mar 25. Review.

PMID:
30928168
13.

Pregnancy-Adapted YEARS Algorithm for Diagnosis of Suspected Pulmonary Embolism.

van der Pol LM, Tromeur C, Bistervels IM, Ni Ainle F, van Bemmel T, Bertoletti L, Couturaud F, van Dooren YPA, Elias A, Faber LM, Hofstee HMA, van der Hulle T, Kruip MJHA, Maignan M, Mairuhu ATA, Middeldorp S, Nijkeuter M, Roy PM, Sanchez O, Schmidt J, Ten Wolde M, Klok FA, Huisman MV; Artemis Study Investigators.

N Engl J Med. 2019 Mar 21;380(12):1139-1149. doi: 10.1056/NEJMoa1813865.

PMID:
30893534
14.

The problem of under-diagnosis and over-diagnosis of pulmonary embolism.

Swan D, Hitchen S, Klok FA, Thachil J.

Thromb Res. 2019 May;177:122-129. doi: 10.1016/j.thromres.2019.03.012. Epub 2019 Mar 14. Review.

PMID:
30889517
15.

Post-thrombotic syndrome: Short and long-term incidence and risk factors.

Ende-Verhaar YM, Tick LW, Klok FA, Huisman MV, Rosendaal FR, le Cessie S, Cannegieter SC.

Thromb Res. 2019 May;177:102-109. doi: 10.1016/j.thromres.2019.03.003. Epub 2019 Mar 6.

PMID:
30870656
16.

Outcomes following pancreatic surgery using three different thromboprophylaxis regimens.

Hanna-Sawires RG, Groen JV, Klok FA, Tollenaar RAEM, Mesker WE, Swijnenburg RJ, Vahrmeijer AL, Bonsing BA, Mieog JSD.

Br J Surg. 2019 May;106(6):765-773. doi: 10.1002/bjs.11103. Epub 2019 Feb 18.

17.

Comment on 'D-dimer and high-sensitivity C-reactive protein levels to predict venous thromboembolism recurrence after discontinuation of anticoagulation for cancer-associated thrombosis'.

Klok FA, Versteeg HH, Verschoor AJ, Huisman MV.

Br J Cancer. 2019 Feb;120(4):472. doi: 10.1038/s41416-018-0361-x. Epub 2019 Jan 30. No abstract available.

PMID:
30696981
18.

Idarucizumab for Dabigatran Reversal in the Management of Patients With Gastrointestinal Bleeding.

Van der Wall SJ, Lopes RD, Aisenberg J, Reilly P, van Ryn J, Glund S, Elsaesser A, Klok FA, Pollack CV Jr, Huisman MV.

Circulation. 2019 Feb 5;139(6):748-756. doi: 10.1161/CIRCULATIONAHA.118.036710. Erratum in: Circulation. 2019 Feb 5;139(6):e36.

PMID:
30586692
19.

Incomplete echocardiographic recovery at 6 months predicts long-term sequelae after intermediate-risk pulmonary embolism. A post-hoc analysis of the Pulmonary Embolism Thrombolysis (PEITHO) trial.

Barco S, Russo M, Vicaut E, Becattini C, Bertoletti L, Beyer-Westendorf J, Bouvaist H, Couturaud F, Danays T, Dellas C, Duerschmied D, Empen K, Ferrari E, Galiè N, Jiménez D, Klok FA, Kostrubiec M, Kozak M, Kupatt C, Lang IM, Lankeit M, Meneveau N, Palazzini M, Pruszczyk P, Rugolotto M, Salvi A, Sanchez O, Schellong S, Sobkowicz B, Meyer G, Konstantinides SV.

Clin Res Cardiol. 2019 Jul;108(7):772-778. doi: 10.1007/s00392-018-1405-1. Epub 2018 Dec 18.

20.

Magnetic resonance direct thrombus imaging for pre-operative assessment of acute thrombosis in chronic thromboembolic pulmonary hypertension.

Klok FA, Pruefer D, Rolf A, Konstantinides SV.

Eur Heart J. 2019 Mar 14;40(11):944. doi: 10.1093/eurheartj/ehy786. No abstract available.

PMID:
30496427
21.

Fatal recurrent VTE after anticoagulant treatment for unprovoked VTE: a systematic review.

van der Wall SJ, van der Pol LM, Ende-Verhaar YM, Cannegieter SC, Schulman S, Prandoni P, Rodger M, Huisman MV, Klok FA.

Eur Respir Rev. 2018 Nov 28;27(150). pii: 180094. doi: 10.1183/16000617.0094-2018. Print 2018 Dec 31.

22.

Elastic compression stockings one year after DVT diagnosis: Who might discontinue?

Mol GC, Dronkers CEA, van de Ree MA, van der Pas SL, Tegelberg-Stassen MJAM, Sanders FBM, Koppen S, de Weerdt O, Koster T, Hovens MMC, Kaasjager HAH, Brouwer RE, Kragten E, Schaar CG, Spiering W, Arnold WP, Huisman MV, Klok FA.

Thromb Res. 2019 Jan;173:35-41. doi: 10.1016/j.thromres.2018.11.002. Epub 2018 Nov 7.

PMID:
30468951
23.

Direct oral anticoagulant use and subsequent start of proton pump inhibitors as proxy for gastric complaints.

Zielinski GD, Teichert M, Klok FA, Rosendaal FR, Huisman MV, Cannegieter SC, Lijfering WM.

Pharmacoepidemiol Drug Saf. 2018 Dec;27(12):1371-1378. doi: 10.1002/pds.4684. Epub 2018 Nov 15.

PMID:
30443944
24.

Determinants of diagnostic delay in chronic thromboembolic pulmonary hypertension: results from the European CTEPH Registry.

Klok FA, Barco S, Konstantinides SV, Dartevelle P, Fadel E, Jenkins D, Kim NH, Madani M, Matsubara H, Mayer E, Pepke-Zaba J, Delcroix M, Lang IM.

Eur Respir J. 2018 Dec 6;52(6). pii: 1801687. doi: 10.1183/13993003.01687-2018. Print 2018 Dec. No abstract available.

PMID:
30409820
25.

Impact of sex, age, and risk factors for venous thromboembolism on the initial presentation of first isolated symptomatic acute deep vein thrombosis.

Barco S, Klok FA, Mahé I, Marchena PJ, Ballaz A, Rubio CM, Adarraga MD, Mastroiacovo D, Konstantinides SV, Monreal M; RIETE Investigators.

Thromb Res. 2019 Jan;173:166-171. doi: 10.1016/j.thromres.2018.09.056. Epub 2018 Sep 27.

PMID:
30385047
26.

Differential impact of syncope on the prognosis of patients with acute pulmonary embolism: a systematic review and meta-analysis.

Barco S, Ende-Verhaar YM, Becattini C, Jimenez D, Lankeit M, Huisman MV, Konstantinides SV, Klok FA.

Eur Heart J. 2018 Dec 14;39(47):4186-4195. doi: 10.1093/eurheartj/ehy631.

PMID:
30339253
27.

Performance of idarucizumab as antidote of dabigatran in daily clinical practice.

van der Wall SJ, van Rein N, van den Bemt B, Kruip MJHA, Meijer K, Te Boome LCJ, Simmers TA, Alings AMW, Tieleman R, Klok FA, Huisman MV, Westerweel PE.

Europace. 2019 Mar 1;21(3):414-420. doi: 10.1093/europace/euy220.

PMID:
30339226
28.

Safety of D-dimer testing as a stand-alone test for the exclusion of deep vein thrombosis as compared with other strategies.

Fronas SG, Wik HS, Dahm AEA, Jørgensen CT, Gleditsch J, Raouf N, Klok FA, Ghanima W.

J Thromb Haemost. 2018 Dec;16(12):2471-2481. doi: 10.1111/jth.14314. Epub 2018 Nov 20.

PMID:
30303610
29.

The impact of post-pulmonary embolism syndrome and its possible determinants.

Tavoly M, Wik HS, Sirnes PA, Jelsness-Jørgensen LP, Ghanima JP, Klok FA, Sandset PM, Ghanima W.

Thromb Res. 2018 Nov;171:84-91. doi: 10.1016/j.thromres.2018.09.048. Epub 2018 Sep 15.

PMID:
30267974
30.

Determining the minimal clinically important difference for the PEmbQoL questionnaire, a measure of pulmonary embolism-specific quality of life.

Akaberi A, Klok FA, Cohn DM, Hirsch A, Granton J, Kahn SR.

J Thromb Haemost. 2018 Dec;16(12):2454-2461. doi: 10.1111/jth.14302. Epub 2018 Nov 2.

PMID:
30240543
31.

Correction to: Antithrombotic therapy after mitral valve repair: VKA or aspirin?

van der Wall SJ, Olsthoorn JR, Heuts S, Klautz RJM, Tomsic A, Jansen EK, Vonk ABA, Sardari Nia P, Klok FA, Huisman MV.

J Thromb Thrombolysis. 2018 Nov;46(4):482. doi: 10.1007/s11239-018-1735-x.

PMID:
30203248
32.

Lower prevalence of subsegmental pulmonary embolism after application of the YEARS diagnostic algorithm.

van der Pol LM, Bistervels IM, van Mens TE, van der Hulle T, Beenen LFM, den Exter PL, Kroft LJM, Mairuhu ATA, Middeldorp S, van Werkhoven JM, Ten Wolde M, Huisman MV, Klok FA.

Br J Haematol. 2018 Nov;183(4):629-635. doi: 10.1111/bjh.15556. Epub 2018 Sep 10.

33.

Antithrombotic therapy after mitral valve repair: VKA or aspirin?

van der Wall SJ, Olsthoorn JR, Heuts S, Klautz RJM, Tomsic A, Jansen EK, Vonk ABA, Sardari Nia P, Klok FA, Huisman MV.

J Thromb Thrombolysis. 2018 Nov;46(4):473-481. doi: 10.1007/s11239-018-1724-0. Erratum in: J Thromb Thrombolysis. 2018 Sep 10;:.

34.

Predictive value of venous thromboembolism (VTE)-BLEED to predict major bleeding and other adverse events in a practice-based cohort of patients with VTE: results of the XALIA study.

Klok FA, Barco S, Turpie AGG, Haas S, Kreutz R, Mantovani LG, Gebel M, Herpers M, Bugge JP, Kostantinides SV, Ageno W.

Br J Haematol. 2018 Nov;183(3):457-465. doi: 10.1111/bjh.15533. Epub 2018 Aug 19.

35.

Computed tomography pulmonary angiography versus ventilation-perfusion lung scanning for diagnosing pulmonary embolism during pregnancy: a systematic review and meta-analysis.

Tromeur C, van der Pol LM, Le Roux PY, Ende-Verhaar Y, Salaun PY, Leroyer C, Couturaud F, Kroft LJM, Huisman MV, Klok FA.

Haematologica. 2019 Jan;104(1):176-188. doi: 10.3324/haematol.2018.196121. Epub 2018 Aug 16.

36.

Healthcare utilization in chronic thromboembolic pulmonary hypertension after acute pulmonary embolism.

Ende-Verhaar YM, van den Hout WB, Bogaard HJ, Meijboom LJ, Huisman MV, Symersky P, Vonk-Noordegraaf A, Klok FA.

J Thromb Haemost. 2018 Nov;16(11):2168-2174. doi: 10.1111/jth.14266. Epub 2018 Aug 30.

PMID:
30099844
37.

Home treatment of acute pulmonary embolism: state of the art in 2018.

van der Wall SJ, Hendriks SV, Huisman MV, Klok FA.

Curr Opin Pulm Med. 2018 Sep;24(5):425-431. doi: 10.1097/MCP.0000000000000512. Review.

PMID:
30020141
38.

Management and treatment of deep vein thrombosis in special populations.

Boon GJAM, Van Dam LF, Klok FA, Huisman MV.

Expert Rev Hematol. 2018 Sep;11(9):685-695. doi: 10.1080/17474086.2018.1502082. Epub 2018 Jul 25. Review.

PMID:
30016119
39.

Pharmacological properties of betrixaban.

Huisman MV, Klok FA.

Eur Heart J Suppl. 2018 May;20(Suppl E):E12-E15. doi: 10.1093/eurheartj/suy016. Epub 2018 May 9.

40.

Less abnormal uterine bleeding with dabigatran than warfarin in women treated for acute venous thromboembolism.

Huisman MV, Ferreira M, Feuring M, Fraessdorf M, Klok FA.

J Thromb Haemost. 2018 Sep;16(9):1775-1778. doi: 10.1111/jth.14226. Epub 2018 Aug 11.

PMID:
29974611
41.

Predicting Post-Thrombotic Syndrome with Ultrasonographic Follow-Up after Deep Vein Thrombosis: A Systematic Review and Meta-Analysis.

Dronkers CEA, Mol GC, Maraziti G, van de Ree MA, Huisman MV, Becattini C, Klok FA.

Thromb Haemost. 2018 Aug;118(8):1428-1438. doi: 10.1055/s-0038-1666859. Epub 2018 Jul 4.

PMID:
29972864
42.

Abnormal vaginal bleeding in women of reproductive age treated with edoxaban or warfarin for venous thromboembolism: a post hoc analysis of the Hokusai-VTE study.

Scheres L, Brekelmans M, Ageno W, Ay C, Büller HR, Eichinger S, Hutten BA, Klok FA, Middeldorp S, Schreiber K, Stach K, Blondon M, Delluc A.

BJOG. 2018 Nov;125(12):1581-1589. doi: 10.1111/1471-0528.15388. Epub 2018 Jul 20.

43.

Novel Anticoagulant Treatment for Pulmonary Embolism with Direct Oral Anticoagulants Phase 3 Trials and Clinical Practice.

Tromeur C, van der Pol LM, Mairuhu ATA, Leroyer C, Couturaud F, Huisman MV, Klok FA.

Semin Intervent Radiol. 2018 Jun;35(2):83-91. doi: 10.1055/s-0038-1642622. Epub 2018 Jun 4. Review.

44.

Persistence to direct oral anticoagulants for acute venous thromboembolism.

Dronkers CEA, Lijfering WM, Teichert M, van der Meer FJM, Klok FA, Cannegieter SC, Huisman MV.

Thromb Res. 2018 Jul;167:135-141. doi: 10.1016/j.thromres.2018.05.013. Epub 2018 May 19.

PMID:
29843087
45.

Pulmonary embolism.

Huisman MV, Barco S, Cannegieter SC, Le Gal G, Konstantinides SV, Reitsma PH, Rodger M, Vonk Noordegraaf A, Klok FA.

Nat Rev Dis Primers. 2018 May 17;4:18028. doi: 10.1038/nrdp.2018.28. Review.

PMID:
29770793
46.

Questioning the use of an age-adjusted D-dimer threshold to exclude venous thromboembolism: comment.

Kraaijpoel N, Toorop MMA, Bossuyt PM, Klok FA, Büller HR, van Es N.

J Thromb Haemost. 2018 Jul;16(7):1445-1448. doi: 10.1111/jth.14133. Epub 2018 Jun 12. No abstract available.

PMID:
29733495
47.

Clinical effects of antiplatelet drugs and statins on D-dimer levels.

Schol-Gelok S, van der Hulle T, Biedermann JS, van Gelder T, Klok FA, van der Pol LM, Versmissen J, Huisman MV, Kruip MJHA.

Eur J Clin Invest. 2018 Jul;48(7):e12944. doi: 10.1111/eci.12944. Epub 2018 May 13.

48.

Chronic thromboembolic pulmonary hypertension from the perspective of patients with pulmonary embolism.

Klok FA, Delcroix M, Bogaard HJ.

J Thromb Haemost. 2018 Jun;16(6):1040-1051. doi: 10.1111/jth.14016. Epub 2018 May 8. Review.

PMID:
29608809
49.

Follow-up after acute Pulmonary Embolism.

Klok FA, Barco S.

Hamostaseologie. 2018 Feb;38(1):22-32. doi: 10.5482/HAMO-17-06-0020. Epub 2018 Feb 26. Review.

PMID:
29536477
50.

Evaluation of VTE-BLEED for predicting intracranial or fatal bleeding in stable anticoagulated patients with venous thromboembolism.

Klok FA, Barco S, Konstantinides SV.

Eur Respir J. 2018 Apr 19;51(4). pii: 1800077. doi: 10.1183/13993003.00077-2018. Print 2018 Apr. No abstract available.

PMID:
29496756

Supplemental Content

Support Center